Lactate, choline, and creatine levels measured by vitro 1H-MRS as prognostic parameters in patients with non-small-cell lung cancer

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 5, 2007, Pages 992-999

  Yokota, Hajime ^a   Guo, Jianfei ^a   Matoba, Munetaka ^a   Higashi, Kotaro ^a   Tonami, Hisao ^a   Nagao, Yosinobu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

1H MRS; Choline; Creatine; Lactate; Lung cancer; Prognosis

Indexed keywords

CHOLINE; CREATININE; LACTIC ACID;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMAGE ANALYSIS; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROMETER; THORAX RADIOGRAPHY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CHOLINE; CREATINE; FEMALE; HUMANS; LACTATES; LUNG NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 34247892289     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.20902     Document Type: Article

References (30)

1. Takise A, Kodama T, Shimosato Y, Watanabe S, Suemasu K. Histopathologic prognostic factors in adenocarcinomas of the peripheral lung less than 2 cm in diameter. Cancer 1988;61:2082-2088.
2. Van Rens ThMM, Zanen P, De la Rivière AB, et al. Survival after resection of metachronous non-small cell lung cancer in 127 patients. Ann Thorac Surg 2001;71:309-313.
3. 1H MR spectroscopy in patients with metastatic brain tumors: a multicenter study. Magn Reson Med 1995;33:818-826.
4. 1H MRS and in vitro multinuclear MR study of human brain tumors. Anticancer Rec 1996;16:2891-2900.
5. 1H-MRS suggests elevated glycine/inositol levels. Neuroradiology 1999;41:650-653.
6. Li X, Vigneron BD, Cha S, et al. Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo. AJNR Am J Neuroradiol 2005;26:760-769.
7. Walenta S, Salameh A, Lyng H, et al. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 1997;150:409-415.
8. Walenta S, Wetterling M, Lehrke M, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res 2000;60:916-921.
9. Walenta S, Salameh A, Lyng H, et al. Correlation of high lactate levels in human and neck tumors with incidence of metastasis. Am J Pathol 1997;150:409-415.
10. Sitter B, Bathen T, Hagen B, Arentz C, Skjeldestad EF, Gribbestad SI. Cervical cancer tissue characterized by high-resolution magic angle spinning MR spectroscopy. MAGMA 2004;16:174-181.
11. 1H-MRS of excised rabbit lung: evaluation of preservation method of the lung using 10%DMSO solution. Radiat Med 2005;23:590-593.
12. 1H-NMR spectroscopy. NMR Biomed 2002;15:37-44.
13. 1H nuclear magnetic resonance spectroscopy of tissue extracts and discriminant factor analysis. Magn Reson Med 1993;29:436-440.
14. Poptani H, Gupta KR, Roy R, Pandey R, Jain KV, Chhabra KD. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. AJNR Am J Neuroradiol 1995;16:1593-1603.
15. 1H NMR Spectroscopy in fifty cases of newly diagnosed intracranial tumors. J Comput Assist Tomogr 1991;15:67-76.
16. Yoshino E, Ohmori Y, Imahori Y, et al. Irradiation effects on the metabolism of metastatic hrain tumor: analysis by position emission tomography and IH-magnetic resonance spectroscopy. Stereotact Funct Neurosurg 1996;66:240-259.
17. Schwickert G, Walenta S, Sundfør K, Rofstad KE, Mueller-Klieser W. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 1995;55:4757-4759.
18. Barker BP, Breiter NS, Soher JB, et al. Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994;32:157-163.
19. Wald LL, Nelson JS, Day RM, et al. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy. J Neurosurg 1997;85:525-534.
20. Herminghaus S, Pilatus U, Möller-Hartmann W, et al. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors. NMR Biomed 2002;15:385-392.
21. Girard N, Wang ZJ, Erbetta A, et al. Prognostic value of proton MR spectroscopy of cerebral hemisphere tumors in children. Neuroradiology 1998;40:121-125.
22. Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T. Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 2000;42:333-338.
23. Fountas NK, Kapsalaki ZE, Vogel LR, Fezoulidis I, Robinson SJ, Gotsis DE. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy. Stereotact Funct Neurosurg 2004;82:90-97.
24. Tarnawski R, Sokol M, Pieniazek P, et al. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002;52:1271-1276.
25. Law M, Yang S, Wang H, et al. Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003;24:1989-1998.
26. 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma. J Nucl Med 2004;45:1334-1339.
27. 1H MR spectroscopy of human head and neck lymph node metastasis and comparison with oxygen tension measurements. AJNR Am J Neuroradiol 2000;21:183-193.
28. Brizel MD, Sibley SG, Prosnitz RL, Scher LR, Dewhirst WM. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38:285-289.
29. Brizel MD, Scully PS, Harrelson MJ, et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 1996;56:941-943.
30. Lear LJ. Glycolysis: Link between PET and proton MR spectroscopic studies of the brain. Radiology 1990;174:328-330.